Navigation Links
Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010
Date:12/15/2009

BRIARCLIFF MANOR, N.Y., Dec. 15 /PRNewswire/ -- On January 20th, 2010, the inaugural European meeting of the International Society for Medical Publication Professionals (ISMPP) will be held at the Royal College of Physicians in London, UK. More than 100 attendees are expected at this prestigious event, providing a new forum for publication professionals, editors, publishers, medical writers and medical agencies to discuss the changing world of medical publications and the impact of guidelines and regulations such as GPP-2, FDAAA and impending clinical trial disclosure legislation in Europe.

As Al Weigel, President of ISMPP, noted, "Medical publication planning, regardless of where you reside, must be approached from an international perspective. ISMPP's commitment to the growth of our EU membership reflects this reality, and starts with the need to provide our members with regionalized education and support."

ISMPP is delighted to announce an outstanding group of renowned experts who will chair sessions on key aspects of medical publications:

  • Chris Graf (ISMPP and Wiley-Blackwell): Good Publication Planning Guidelines 2 - what is new and the need for the change: interactive session
  • Liz Wager from the Committee on Publication Ethics (COPE): Medical Publications - a historical perspective
  • Fergus Sweeney (European Medicines Agency), who will discuss EudraCT (European Union Drug Regulating Authorities Clinical Trials): clinical trial protocol posting and results disclosure in Europe

Key sessions with interactive debates on:

  • The future of scientific communications.
  • Marketing involvement in publication planning and delivery.
  • The role of medical writers and the role of the pharmaceutical industry in opinion pieces and review articles.

For more information and to register to attend or sponsor this event, please go to http://www.ismpp.org.

About the International Society for Medical Publication Professionals: ISMPP is an independent non-profit professional association with members from the pharmaceutical, medical device, and biotechnology industries; publication planning and medical communication companies; academia; and medical journal staff, including editors and publishers. Its goals are to support the educational needs of publication professionals and to develop best practices that ensure the rigorous maintenance of all ethical standards for reporting results of medical research. Additional information about ISMPP is available by contacting the organization's Executive Director, Kimberly Goldin (phone: +1 914-945-0507; email: kgoldin@ismpp.org), or online at http://www.ismpp.org.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE International Society for Medical Publication Professionals


'/>"/>
SOURCE International Society for Medical Publication Professionals
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Announcing Sustainability in Packaging 2010: Strategies to make sustainability sustainable
2. ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ
3. ISMPP Supports Best Practices and Transparency in Medical Publications: Better Understanding of Terms Such as Ghostwriting Needed
4. International Society for Medical Publication Professionals (ISMPP) Announces First CMPP Exam Window Closes, Next Opportunity in September
5. ISMPP Applauds AAMC Clarification on Ghostwriting Versus Transparent Writing Collaboration in Scientific Publications
6. Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials
7. Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure
8. Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia
9. Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans
10. Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Companys First Annual 2010 Micro Cap Conference
11. Waters Ships First Units of SYNAPT G2 Mass Spectrometer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... ... to transform technology into a viable company, CereScan’s CEO, John Kelley, joined other ... a recognized leader and mentor in the Denver area business community, shared his ...
(Date:4/28/2016)... 2016 Q BioMed Inc. ... CEO  was featured in an article he wrote ... Fear To Tread: http://www.lifescienceleader.com/doc/accelerators-enter-when-vcs-fear-to-tread-0001 ... is an essential business journal for life science ... to Big Pharmas. Their content is designed to ...
(Date:4/27/2016)... ... April 27, 2016 , ... Cambridge Semantics, the ... technology, today announced that it has been named to The Silicon Review’s “20 Fastest ... and other markets, Cambridge Semantics serves the needs of end users facing some of ...
(Date:4/27/2016)... and RESEARCH TRIANGLE PARK, N.C. ... UTHR ) announced today that Martine ... United Therapeutics will provide an overview and update on ... Annual Health Care Conference. The presentation ... 10:00 a.m. Eastern Time, and can be accessed via ...
Breaking Biology Technology:
(Date:4/14/2016)... TEL AVIV, Israel , April 14, 2016 /PRNewswire/ ... in Behavioral Authentication and Malware Detection, today announced the ... has already assumed the new role. Goldwerger,s ... for BioCatch, on the heels of the deployment of ... In addition, BioCatch,s behavioral biometric technology, which discerns unique ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):